NOVEN PHARMACEUTICALS INC
10-Q, EX-27, 2000-08-11
PHARMACEUTICAL PREPARATIONS
Previous: NOVEN PHARMACEUTICALS INC, 10-Q, 2000-08-11
Next: ACM GOVERNMENT INCOME FUND INC, N-14AE, N-14, 2000-08-11



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY UNAUDITED FINANCIAL INFORMATION EXTRACTED FROM
NOVEN PHARMACEUTICALS, INC. FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          18,798
<SECURITIES>                                         0
<RECEIVABLES>                                    4,480
<ALLOWANCES>                                       156
<INVENTORY>                                      5,315
<CURRENT-ASSETS>                                32,123
<PP&E>                                          21,882
<DEPRECIATION>                                   6,696
<TOTAL-ASSETS>                                  64,165
<CURRENT-LIABILITIES>                            9,341
<BONDS>                                              0
                                0
                                          0
<COMMON>                                             2
<OTHER-SE>                                      69,162
<TOTAL-LIABILITY-AND-EQUITY>                    64,165
<SALES>                                         19,791
<TOTAL-REVENUES>                                20,084
<CGS>                                            9,023
<TOTAL-COSTS>                                   18,792
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 467
<INCOME-PRETAX>                                  5,489
<INCOME-TAX>                                       188
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     5,301
<EPS-BASIC>                                        .24
<EPS-DILUTED>                                      .23


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission